The left point of smart health technology brand has won more than 100 million yuan a + round financing, leading investment of strategic venture capital
According to the scientific and technological innovation board on the 12th, the left point of intelligent health care technology brand has completed a + round financing of more than 100 million yuan, led by GL ventures, Qingliu capital, Tiantu investment, Tongchuang Weiye, Biguiyuan venture capital, and Qichen capital acted as the exclusive financial consultant. Zhu Jiangtao, the founder of left point, said that this round of financing will continue to invest in product research and development on a larger scale, and continue to consolidate patent barriers and market promotion. Previously, the left point obtained a round financing of tens of millions of RMB invested by Tiantu in April this year, and obtained the pre-A round financing of ten million RMB from Haiquan fund in October 2019.
This text is a result of machine translation.
Related companies：
In-depth
Healthcare, Technology
Pure Global: The International Engine of Medical Technology Globalization
As a pioneer in international regulatory management and clinical solutions, Pure Global has evolved into an indispensable partner for medical technology companies. Through its outstanding data technology, seasoned industry expert team, and transnational capabilities, Pure Global empowers its partners to achieve global growth. Presently, Pure Global's services span more than 25 countries and regions, offering tailored solutions for the entire lifecycle of medical devices.
Sep 28, 2023 09:30 AM
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 18, 2022 06:30 PM
Healthcare
Cellatopia Secures Nearly CNY Ten Mn in Seed Funding
EqualOcean has learned that Cellatopia(喜同生物), a biotechnology company based in Suzhou, recently announced the successful securing of nearly CNY ten million in seed funding. The funding was primarily led by Suzhou Shishangbai Venture Capital(苏州石上柏创业合伙企业) and followed by institutions such as Suzhou Nuowei Venture Investment Limited(苏州诺为创业投资有限公司).
Apr 18, 2024 01:25 PM
Healthcare
Haier Biomedical 'Smart Blood City Network' Lands in Brazil
Brazil, as the largest country and economy in South America, faces numerous challenges brought about by an aging population. With the country's economy continuing to grow, healthcare issues are receiving increasing attention, and the demand for medical services is rising year by year.
Apr 15, 2024 03:45 PM
Briefing Mar 13, 2022 08:49 PM
· Financials
Capital group, an asset management institution, launched ETF products for the first time: buying Chinese stocks such as Guizhou Maotai, Yaoming biology and meituan
Healthcare
D3 Bio Completes A+ Round Financing, Accelerates Development of Product Pipeline
EqualOcean has learned that on April 8, 2024, D3 Bio(德昇济医药), a biotechnology company focused on the development and commercialization of innovative cancer and immune precision therapies, announced the successful completion of its A+ round financing led by Medicxi, a prominent European life sciences investment firm. The financing amounted to USD 62 million, with existing investor, Matrix Partners(经纬创投), also participating.
Apr 12, 2024 06:05 PM
Briefing Feb 14, 2022 11:49 PM
· Consumer Staples
Country Garden Service: it plans to acquire about 93.76% equity of Zhongliang Baiyue Zhijia service
See more
Read next
Insight
In-depth
Insight
In-depth